Form 4: Bio-Rad Laboratories CEO Receives Stock Grant
Insider Transaction (Form 4)
Norman D Schwartz, Chairman & CEO, a Director and 10% owner of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on September 4, 2026.
Summary
- Option exercise/conversion: acquired 4,109 Bio-Rad A Common Stock on September 5, 2026; holds 450,294 after (Direct).
- Tax/exercise-price withholding: disposed of 2,876 Bio-Rad A Common Stock at $386.11 ($1,110,452) on September 5, 2026; holds 447,418 after (Direct).
- Option exercise/conversion: acquired 3,455 Bio-Rad A Common Stock on September 6, 2026; holds 450,873 after (Direct).
- Tax/exercise-price withholding: disposed of 1,854 Bio-Rad A Common Stock at $386.11 ($715,848) on September 6, 2026; holds 449,019 after (Direct).
- Grant/award: acquired 17,251 Restricted Stock Units on September 4, 2026; holds 17,251 after (Direct).
- Option exercise/conversion: disposed of 4,109 Restricted Stock Units on September 5, 2026; holds 12,330 after (Direct).
- Option exercise/conversion: disposed of 3,455 Restricted Stock Units on September 6, 2026; holds 6,912 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Norman D Schwartz — Director, Officer (Chairman & CEO), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Option exercise/conversion | Bio-Rad A Common Stock | 4,109 | — | — | 450,294 |
| 2026-09-05 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 2,876 | $386 | $1.1M | 447,418 |
| 2026-09-06 | Option exercise/conversion | Bio-Rad A Common Stock | 3,455 | — | — | 450,873 |
| 2026-09-06 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 1,854 | $386 | $715.8K | 449,019 |
| 2026-09-04 | Grant/award | Restricted Stock Units | 17,251 | — | — | 17,251 |
| 2026-09-05 | Option exercise/conversion | Restricted Stock Units | 4,109 | — | — | 12,330 |
| 2026-09-06 | Option exercise/conversion | Restricted Stock Units | 3,455 | — | — | 6,912 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Option exercise/conversion (4,109 shares) |
| 2026-09-05 | Tax/exercise-price withholding (2,876 shares) |
| 2026-09-06 | Option exercise/conversion (3,455 shares) |
| 2026-09-06 | Tax/exercise-price withholding (1,854 shares) |
| 2026-09-04 | Grant/award (17,251 shares) |
| 2026-09-05 | Option exercise/conversion (4,109 shares) |
| 2026-09-06 | Option exercise/conversion (3,455 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Norman D Schwartz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.